Safeguard Scientifics, Inc. engages in the provision capital to technology-driven businesses in healthcare, financial services, and digital media. The company is headquartered in Radnor, Pennsylvania. The firm offers strategic, operational and management support to certain of its ownership interests, which include defining short and long-term strategic goals; identifying and planning for the critical success factors to reach these goals; identifying and addressing the challenges and operational improvements required to achieve the critical success factors and, ultimately, the strategic goals; identifying and implementing the business measurements that the Company and others are apply to measure a company’s success; and identifying sources of and providing capital to drive growth. The company also continues to hold relatively small equity interests in other enterprises where it does not exert significant influence and do not participate in management activities. The firm's subsidiaries include Bonfield VII, Ltd., Safeguard Delaware, Inc., SFE Properties, Inc., and others.
Leveraging in-depth analyst evaluations, we have synthesized key insights from expert assessments to present a positive outlook for SFES. Analysts highlight solid fundamentals and favorable market sentiment, suggesting upside potential in the near term. Based on this thorough expert analysis, we maintain an optimistic view of this stock. Our conclusion: SFES is a Buy candidate.
SFES stock price ended at $0.76 on 星期三, after rising 0.00%
On the latest trading day Jan 21, 2026, the stock price of SFES rose by 0.00%, climbing from $0.77 to $0.76. During the session, the stock saw a volatility of 1.32%, with prices oscillating between a daily low of $0.76 and a high of $0.77. Notably, trading volume dropped by 211.2K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 247.2K shares were traded, equating to a market value of approximately $12.7M.